Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. (Q51689510)

9 April 2018

title

Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. (English)

1 reference

9 April 2018

1 reference

6

1 reference

9 April 2018

Hugo A. Katus

9

object named as

Hugo A Katus

1 reference

9 April 2018

author name string

Arnt V Kristen

1

1 reference

9 April 2018

Johannes Rinn

2

1 reference

9 April 2018

Ute Hegenbart

3

1 reference

9 April 2018

David Lindenmaier

4

1 reference

9 April 2018

Corina Merkle

5

1 reference

9 April 2018

Stefan Hardt

7

1 reference

9 April 2018

Evangelos Giannitsis

8

1 reference

9 April 2018

publication date

21 October 2014

1 reference

9 April 2018

Clinical Research in Cardiology

published in

1 reference

9 April 2018

volume

104

1 reference

9 April 2018

page(s)

250-257

1 reference

9 April 2018

issue

3

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1007/s00392-014-0779-y

exact match

0 references

cites work

Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Rapid assessment of longitudinal systolic left ventricular function using speckle tracking of the mitral annulus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Survival in patients with primary systemic amyloidosis and raised serum cardiac troponins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Vascular abnormalities in primary amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Endothelial dysfunction precedes C-fiber abnormalities in primary (AL) amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Vascular endothelial growth factor (VEGF) signaling in tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Prognostic value of placental growth factor in patients with acute chest pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Role of placenta growth factor in cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Cell type-specific expression of neuropilins in an MCA-occlusion model in mice suggests a potential role in post-ischemic brain remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Highly sensitive cardiac troponin T values remain constant after brief exercise- or pharmacologic-induced reversible myocardial ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Connective tissue growth factor (CTGF/CCN2): diagnostic and prognostic value in acute heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Assignment of vascular endothelial growth factor (VEGF) and placenta growth factor (PLGF) genes to human chromosome 6p12-p21 and 14q24-q31 regions, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Green tea halts progression of cardiac transthyretin amyloidosis: an observational report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00392-014-0779-Y

Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts

21 January 2018

1 reference

12 December 2020

Holter monitoring in AL amyloidosis: prognostic implications

1 reference

12 December 2020

Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction

1 reference

12 December 2020

Elevated Placental Growth Factor (PlGF) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients with Diabetic Nephropathy

1 reference

12 December 2020

Noninvasive diagnosis of biopsy-proven cardiac amyloidosis

1 reference

12 December 2020

Rapid progression of left ventricular wall thickness predicts mortality in cardiac light-chain amyloidosis

1 reference

12 December 2020

Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis

1 reference

12 December 2020

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

12 December 2020

Analytical validation of a high-sensitivity cardiac troponin T assay

1 reference

12 December 2020

Non-invasive predictors of survival in cardiac amyloidosis

1 reference

12 December 2020

Systemic amyloidosis presenting with angina pectoris

1 reference

12 December 2020

Structure, expression and receptor-binding properties of placenta growth factor (PlGF)

1 reference

12 December 2020

Amyloidosis and endomyocardial biopsy: Correlation of extent and pattern of deposition with amyloid immunophenotype in 100 cases

1 reference

12 December 2020

10.1007/S00392-014-0779-Y

Identifiers

DOI

1 reference

9 April 2018

PubMed ID

25331161

1 reference

9 April 2018